238 related articles for article (PubMed ID: 30879106)
1. An immunosuppressive macrophage profile attenuates the prognostic impact of CD20-positive B cells in human soft tissue sarcoma.
Tsagozis P; Augsten M; Zhang Y; Li T; Hesla A; Bergh J; Haglund F; Tobin NP; Ehnman M
Cancer Immunol Immunother; 2019 Jun; 68(6):927-936. PubMed ID: 30879106
[TBL] [Abstract][Full Text] [Related]
2. CD163 Is Required for Protumoral Activation of Macrophages in Human and Murine Sarcoma.
Shiraishi D; Fujiwara Y; Horlad H; Saito Y; Iriki T; Tsuboki J; Cheng P; Nakagata N; Mizuta H; Bekki H; Nakashima Y; Oda Y; Takeya M; Komohara Y
Cancer Res; 2018 Jun; 78(12):3255-3266. PubMed ID: 29610117
[TBL] [Abstract][Full Text] [Related]
3. Immune-cell infiltration in high-grade soft tissue sarcomas; prognostic implications of tumor-associated macrophages and B-cells.
Nyström H; Jönsson M; Nilbert M; Carneiro A
Acta Oncol; 2023 Jan; 62(1):33-39. PubMed ID: 36786033
[TBL] [Abstract][Full Text] [Related]
4. Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma.
Gartrell-Corrado RD; Chen AX; Rizk EM; Marks DK; Bogardus MH; Hart TD; Silverman AM; Bayan CY; Finkel GG; Barker LW; Komatsubara KM; Carvajal RD; Horst BA; Chang R; Monod A; Rabadan R; Saenger YM
Cancer Res; 2020 Mar; 80(5):1078-1087. PubMed ID: 31948941
[TBL] [Abstract][Full Text] [Related]
5. CD20
Sato J; Kitano S; Motoi N; Ino Y; Yamamoto N; Watanabe S; Ohe Y; Hiraoka N
Cancer Sci; 2020 Jun; 111(6):1921-1932. PubMed ID: 32277550
[TBL] [Abstract][Full Text] [Related]
6. Identification of Prognostic lncRNA Related to the Immune Microenvironment of Soft Tissue Sarcoma.
Dai WY; Wang B; Li JY; Luo ZP
Biomed Res Int; 2022; 2022():9471558. PubMed ID: 35155682
[TBL] [Abstract][Full Text] [Related]
7. Influence of tumor-infiltrating immune cells on local control rate, distant metastasis, and survival in patients with soft tissue sarcoma.
Smolle MA; Herbsthofer L; Goda M; Granegger B; Brcic I; Bergovec M; Scheipl S; Prietl B; El-Heliebi A; Pichler M; Gerger A; Posch F; Tomberger M; López-García P; Feichtinger J; Baumgartner C; Leithner A; Liegl-Atzwanger B; Szkandera J
Oncoimmunology; 2021 Mar; 10(1):1896658. PubMed ID: 33763294
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer.
Lundgren S; Berntsson J; Nodin B; Micke P; Jirström K
J Ovarian Res; 2016 Apr; 9():21. PubMed ID: 27048364
[TBL] [Abstract][Full Text] [Related]
9. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ
Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
Garg K; Maurer M; Griss J; Brüggen MC; Wolf IH; Wagner C; Willi N; Mertz KD; Wagner SN
Hum Pathol; 2016 Aug; 54():157-64. PubMed ID: 27107457
[TBL] [Abstract][Full Text] [Related]
11. The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome.
Arias-Pulido H; Cimino-Mathews A; Chaher N; Qualls C; Joste N; Colpaert C; Marotti JD; Foisey M; Prossnitz ER; Emens LA; Fiering S
Breast Cancer Res Treat; 2018 Sep; 171(2):273-282. PubMed ID: 29858752
[TBL] [Abstract][Full Text] [Related]
12. MS4A1 expression and function in T cells in the colorectal cancer tumor microenvironment.
Mudd TW; Lu C; Klement JD; Liu K
Cell Immunol; 2021 Feb; 360():104260. PubMed ID: 33352466
[TBL] [Abstract][Full Text] [Related]
13. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.
Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L
Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833
[TBL] [Abstract][Full Text] [Related]
14. PLCG2 as a potential indicator of tumor microenvironment remodeling in soft tissue sarcoma.
Li Z; Zhao R; Yang W; Li C; Huang J; Wen Z; Du G; Jiang L
Medicine (Baltimore); 2021 Mar; 100(11):e25008. PubMed ID: 33725976
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer.
Berntsson J; Nodin B; Eberhard J; Micke P; Jirström K
Int J Cancer; 2016 Sep; 139(5):1129-39. PubMed ID: 27074317
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma.
Kim C; Kim EK; Jung H; Chon HJ; Han JW; Shin KH; Hu H; Kim KS; Choi YD; Kim S; Lee YH; Suh JS; Ahn JB; Chung HC; Noh SH; Rha SY; Kim SH; Kim HS
BMC Cancer; 2016 Jul; 16():434. PubMed ID: 27393385
[TBL] [Abstract][Full Text] [Related]
17. The Two Faces of Tumor-Associated Macrophages and Their Clinical Significance in Colorectal Cancer.
Pinto ML; Rios E; Durães C; Ribeiro R; Machado JC; Mantovani A; Barbosa MA; Carneiro F; Oliveira MJ
Front Immunol; 2019; 10():1875. PubMed ID: 31481956
[TBL] [Abstract][Full Text] [Related]
18. Use of quantitative real-time PCR to determine immune cell density and cytokine gene profile in the tumor microenvironment.
Mocellin S; Provenzano M; Rossi CR; Pilati P; Nitti D; Lise M
J Immunol Methods; 2003 Sep; 280(1-2):1-11. PubMed ID: 12972183
[TBL] [Abstract][Full Text] [Related]
19. Macrophages and prognosis of oral squamous cell carcinoma: A systematic review.
Alves AM; Diel LF; Lamers ML
J Oral Pathol Med; 2018 May; 47(5):460-467. PubMed ID: 28940738
[TBL] [Abstract][Full Text] [Related]
20. A seven-gene signature and the C-C motif chemokine receptor family genes are the sarcoma-related immune genes.
Chen J; Liang T; Cen J; Jiang J; Pan S; Huang S; Chen L; Sun X; Li H; Chen T; Liang W; Liao S; Yu C; Yao Y; Ye Z; Chen W; Guo H; Zhan X; Liu C
Bioengineered; 2021 Dec; 12(1):7616-7630. PubMed ID: 34605725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]